Intervention
Time-restricted eating (reviewed trial regimens)
Research Observatory
Evidence Update
Current evidence
In the corrected TREAT trial, restricting eating to noon through 8 p.m. did not produce significantly greater weight loss than structured meal timing in adults with overweight or obesity. A secondary measure of limb lean mass was less favourable. Missing data and corrections concerning the intervention’s actual messages limit interpretation; the result does not establish universal muscle harm from time-restricted eating.
In adults with obesity, adding an early eight-hour eating window to calorie restriction did not significantly improve weight loss at twelve months compared with calorie restriction alone. Both groups restricted calories. This is not evidence of equivalence, a comparison with unrestricted eating, or a demonstration of longer life.
What changed
Corrected TREAT did not show greater weight loss from noon-to-eight eating than structured meal timing. Adding an early eight-hour eating window to calorie restriction did not significantly improve twelve-month weight loss over calorie restriction alone.
How to read these findings
TREAT and the later calorie-restriction trial used different regimens and comparators. The 141 randomized / 116 with data figures and corrected participant messages apply only to TREAT.
TREAT did not show superior weight loss; its secondary lean-mass finding is not universal muscle-harm evidence. In the later trial, both groups restricted calories, so it was not fasting versus unrestricted eating. A nonsignificant difference does not prove equivalence.
Accepted limitations and study details
Exact reviewed qualifications are retained below. These details do not add a new accepted claim.
TREAT only — counts, corrections and interpretation
- 141 randomized but only 116 had data; secondary lean-mass result is not universal muscle harm.
- Corrected messages/protocol deviation constrain implementation interpretation.
- Interpretation: 141 randomized versus 116 observed; corrected messages change active comparator description.
Across the two reviewed trials — not shared participant counts
- Design: Two randomized trials with different active controls; TREAT formally corrected twice
- Safety: TREAT secondary lean-mass signal merits caution; separate trial reported no substantial adverse-event difference.
Later calorie-restriction comparator trial
- Both arms received calorie restriction; not fasting versus unrestricted usual care, equivalence, or lifespan evidence.
- Design: Randomized active-control trial
- Safety: No substantial adverse-event difference reported in the abstract; not equivalence.
Why it matters
These findings apply to the studied populations, regimens and outcomes; they do not establish generalized longevity benefit.
Next proof
Longer trials with comparable support, protein assessment and prespecified function/harms. Energy/support-matched trials with longer functional outcomes.